Getinge Stock

Getinge EBIT

The EBIT of Getinge (GETI B.ST) as of Jul 7, 2026 is 4.19 TT SEK.In the previous year, EBIT was 4.48 TT SEK — a change of -6.6% (lower).

EBIT

4.19 TTSEK

YoY

-6.6%

Last updated:

In 2026, Getinge's EBIT was 4.19 TT SEK, a -6.6% increase from the 4.48 TT SEK EBIT recorded in the previous year.

The Getinge EBIT history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT (B SEK)
Date
EBIT (B SEK)
Jan 1, 2015
3.42 base
Jan 1, 2016
2.68 base
Jan 1, 2017
2.26 base
Jan 1, 2018
-0.28 base
Jan 1, 2019
2.7 base
Jan 1, 2020
4.96 base
Jan 1, 2021
4.47 base
Jan 1, 2022
3.88 base
Jan 1, 2023
4.15 base
Jan 1, 2024
4.48 base
Jan 1, 2025
4.19 base
Invalid Date
4.98 base
Invalid Date
5.52 base
Invalid Date
6.12 base
Invalid Date
6.63 base
YEAREBIT (B SEK)
2030 est -
2029 est 6.63
2028 est 6.12
2027 est 5.52
2026 est 4.98
2025 4.19
2024 4.48
2023 4.15
2022 3.88
2021 4.47
2020 4.96
2019 2.7
2018 -0.28
2017 2.26
2016 2.68
2015 3.42
Access this data via the Eulerpool API

Getinge Revenue

Getinge Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2015
30.24 B SEK
3.42 B SEK
1.39 B SEK
Jan 1, 2016
22.17 B SEK
2.68 B SEK
1.19 B SEK
Jan 1, 2017
22.5 B SEK
2.26 B SEK
1.38 B SEK
Jan 1, 2018
24.17 B SEK
-284 M SEK
-967 M SEK
Jan 1, 2019
26.56 B SEK
2.7 B SEK
1.22 B SEK
Jan 1, 2020
29.82 B SEK
4.96 B SEK
3.24 B SEK
Jan 1, 2021
27.05 B SEK
4.47 B SEK
2.97 B SEK
Jan 1, 2022
28.29 B SEK
3.88 B SEK
2.49 B SEK
Jan 1, 2023
31.83 B SEK
4.15 B SEK
2.41 B SEK
Jan 1, 2024
34.76 B SEK
4.48 B SEK
1.64 B SEK
Jan 1, 2025
34.97 B SEK
4.19 B SEK
2.26 B SEK
Invalid Date
35.8 B SEK
4.98 B SEK
3.36 B SEK
Invalid Date
37.48 B SEK
5.52 B SEK
3.8 B SEK
Invalid Date
39.41 B SEK
6.12 B SEK
4.11 B SEK
Invalid Date
43.41 B SEK
6.63 B SEK
4.39 B SEK

Getinge Margins

Getinge stock margins

The Getinge margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Getinge. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Getinge.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2015
46.84 %
11.31 %
4.6 %
Jan 1, 2016
46.9 %
12.08 %
5.36 %
Jan 1, 2017
47.62 %
10.03 %
6.12 %
Jan 1, 2018
45.73 %
-1.17 %
-4 %
Jan 1, 2019
46.9 %
10.15 %
4.6 %
Jan 1, 2020
49.37 %
16.64 %
10.86 %
Jan 1, 2021
50.21 %
16.51 %
10.98 %
Jan 1, 2022
47.4 %
13.72 %
8.8 %
Jan 1, 2023
45.54 %
13.03 %
7.58 %
Jan 1, 2024
47.33 %
12.9 %
4.71 %
Jan 1, 2025
47.63 %
11.97 %
6.46 %
Invalid Date
47.63 %
13.91 %
9.38 %
Invalid Date
47.63 %
14.71 %
10.13 %
Invalid Date
47.63 %
15.54 %
10.43 %
Invalid Date
47.63 %
15.27 %
10.1 %

Getinge Stock analysis

What does Getinge do? Getinge AB is a globally leading company that offers innovative solutions and products for the healthcare industry. The company was founded in Sweden in 1904 and has since had a long history in the medical technology industry. Getinge AB is known for its leading position in the field of medical equipment, including autoclaves, sterilizers, washer-disinfectors, and ventilators. The business model of Getinge AB is focused on the needs of customers in the healthcare sector. The company operates five business areas: Acute Care Therapies, Infection Control, Extended Care, Life Science, and Surgical Workflows. Each of these business areas focuses on specific needs and requirements within the healthcare sector. Getinge AB aims to offer its customers innovative and high-quality products and services worldwide. The company promotes continuous innovation and aims to leverage the potential of cutting-edge technologies in the market to develop solutions that improve the lives of patients and healthcare professionals. Various divisions and products - Acute Care Therapies: One of Getinge AB's main products in the Acute Care Therapies area is extracorporeal membrane oxygenation machines (ECMO). These systems are used to support patients with respiratory failure. Another important product line is the Intra-Aortic Balloon Pump (IABP), which is used to support patients with heart failure or cardiogenic shock. - Infection Control: In the Infection Control area, Getinge AB focuses on developing products to control infections that can be caused by hospital environments and medical instruments. This includes sterilization and disinfection devices, as well as cleaning and disinfection agents. - Extended Care: The Extended Care business area offers products and solutions for non-acute patient care. The company focuses on offering innovative products and services that contribute to improving the quality of care and reducing costs. This includes products such as patient beds, mattresses, and assistive devices. - Life Science: In the Life Science area, Getinge AB offers products and services for the biopharmaceutical industry and for research and development. The company specializes in the development of cleanroom technology, which helps make the production of medications safer and more efficient. - Surgical Workflows: The Surgical Workflows business area focuses on optimizing surgical workflows and increasing efficiency. Getinge AB offers products and services such as operating tables, anesthesia and monitoring systems, and wound care products. In summary, Getinge AB has a long history in the medical technology industry and is a leading company in the field. The company operates five business areas that focus on specific needs and requirements within the healthcare sector. Getinge AB aims to offer its customers worldwide innovative and high-quality products and services. The product range includes a wide range of innovative medical technology products, including autoclaves, sterilizers, washer-disinfectors, ventilators, cleaning and disinfection agents, and other medical technology products. Getinge is one of the most popular companies on Eulerpool.

EBIT Details

Analyzing Getinge's EBIT

Getinge's Earnings Before Interest and Taxes (EBIT) represents the company's operating profit. It is calculated by deducting all operating expenses, including the cost of goods sold (COGS) and operating expenses, from the total revenue, but before accounting for interest and taxes. It provides insights into the company’s operational profitability, excluding the impacts of financing and tax structures.

Year-to-Year Comparison

A yearly comparison of Getinge's EBIT can reveal trends in the company’s operational efficiency and profitability. An increase in EBIT over the years can indicate enhanced operational efficiency or growth in revenue, while a decrease might raise concerns about increased operating costs or declining sales.

Impact on Investments

Getinge's EBIT is a significant metric for investors. A positive EBIT suggests that the company is generating enough revenue to cover its operating expenses, an essential aspect for assessing the company’s financial health and stability. Investors closely monitor EBIT to gauge the company’s profitability and potential for future growth.

Interpreting EBIT Fluctuations

Fluctuations in Getinge’s EBIT can be due to variations in revenue, operating expenses, or both. An increasing EBIT indicates improved operational performance or increased sales, while a declining EBIT can signal rising operational costs or reduced revenue, prompting a need for strategic adjustments.

Frequently Asked Questions about Getinge stock

EBIT of Getinge amounted to 4.48 TT SEK 4.19 TT

The sales revenue is important for evaluating a stock.

EBIT is an acronym for "Earnings Before Interest and Tax" and represents a company's gross profit before taxes and interest are deducted. The EBIT amount is often used as a metric to evaluate a company.

History

The EBIT was originally introduced in the 1940s when the US Internal Revenue Service (IRS) passed a new tax law. This law required companies to calculate their profit before deducting taxes and interest on loans (or "interest and taxes"). Since then, the EBIT has been used as one of the key financial indicators in evaluating a company.

Usage

The EBIT can be used to assess a company by comparing its financial results to a benchmark or a comparative value. The EBIT is also used to determine how much the company's shareholders will receive from its operating income.

Calculation

EBIT is calculated by deducting taxes and interest on loans from the company's net profit. This amount can be calculated in various ways, but the most common method is as follows:

EBIT = Net profit + interest and taxes

Example: Eulerpool: Your source for quantitative stock data At Eulerpool, we are dedicated to providing you with comprehensive and accurate stock information. Our website offers a wide range of tools and features, including charts, stock lists, and more. Whether you are an experienced investor or just starting out, our platform is designed to meet your needs. With our in-depth analytics and algorithms, you can make informed decisions and stay ahead of the market. Explore our extensive collection of stocks, track their performance, and access real-time data. With Eulerpool, you can easily navigate the world of finance and monitor the stocks that matter to you. Join our community today and gain valuable insights into the world of stocks and investments. Sign up for free and discover the power of Eulerpool. Stay informed. Stay ahead. Eulerpool - your trusted partner in stock data.
Net profit of XYZ Co. = $1,000,000
Interest and taxes = $ 500,000
EBIT of XYZ Co. = $1,500,000

Application

The EBIT value is often used to determine and evaluate the financial stability of a company. The EBIT value can also be used to determine how much money a company can spend on investments or dividends.

Use of EBIT in stock investment

Investors use EBIT to determine if a stock is over- or undervalued. If a company has a high EBIT value, it may indicate that its stock is overvalued, as the profit it generates could be lower than what it would generate with a different stock.

Advantages of EBIT

EBIT is a helpful measure for determining the financial stability of a company. There are several advantages associated with using EBIT, such as:
- EBIT eliminates the impact of financing on the company's earnings.
- It is a useful measure for determining the profits that a company can distribute to its shareholders.
- It can be used to determine whether a stock is overvalued or undervalued.

Disadvantages of EBIT

There are also some disadvantages to using EBIT, such as:
- EBIT cannot be used as the sole measure to evaluate a company as it does not reflect the overall profit of the company.
- EBIT can be influenced by unforeseen events such as a tax increase.
- EBIT is not always a reliable indicator of a company's future profit development.

Conclusion

The EBIT is an important measure used to evaluate a company. It can be used to determine how much money a company can generate from its operational results and whether a stock is overvalued or undervalued. However, the EBIT also has some disadvantages as it does not reflect the overall profitability of a company and can be influenced by unforeseen events. Therefore, it is important to consider the EBIT in conjunction with other financial indicators to obtain a complete picture of the company.

Access this data via the Eulerpool API

Income Statement — Getinge

All Key Metrics — Getinge